. . . . . . . "[Approximately 50% of patients with CH-C treated with pegylated interferon-? and ribavirin (PEG-IFN-? + RBV) achieve a sustained virological response (SVR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:36+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .